News & Updates

Genistein significantly improves immediate recall, verbal learning, executive function, attention, and immediate visual memory and slows down amyloid-beta deposition in the anterior cingulate gyrus of patients with prodromal Alzheimer’s disease (AD), according to the results of the randomized, double-blind, placebo-controlled phase II GENIAL study.

A randomized, double-blind, placebo-controlled, crossover clinical study has found that a single subcutaneous injection of bremelanotide significantly increases sexual desire for up to 24 hours through enhancing sexual brain processing in women with hypoactive sexual desire disorder (HSDD).

As a first-line antiseizure medication (ASM) for infants, levetiracetam (LEV) is potentially noninferior to phenobarbital (PB) and shows a more acceptable safety profile, a new study has found.

Adolescent boys with high body mass index (BMI) are highly likely to develop early-onset atrial fibrillation (AF) with subsequently worse clinical outcomes, including all-cause mortality, heart failure, and stroke, according to a study.

There appears to be evidence suggesting that hyperbaric oxygen therapy does not yield motor and cognitive benefits in children with cerebral palsy, a recent study has found.

Smartphone-based real-life activity data can be used to track physical performance in patients after lumbar spine surgery for degenerative lumbar disorders (DLD), according to a recent study.

In infants born with extremely low birth weight (ELBW), parenteral nutrition supplement using a mixed lipid emulsion containing fish oil does not result in neurodevelopmental or behavioural benefits at preschool age, a new study has found.